GENESIS Pharma
Georgios Zavitsanakis has a strong background in business development and sales with experience in the biopharma, technology, and consulting sectors. Currently working at Genesis Pharma, Georgios is dedicated to providing innovative biopharma therapies to patients in South East Europe. Prior to their current role, Georgios held positions at Logicom Solutions and Accenture, where Georgios demonstrated their expertise in defining strategies and conducting business development activities. With a degree in Electrical and Electronic Engineering from Imperial College London and an MBA from London Business School, Georgios is well-equipped to drive growth and development in their field.
This person is not in any teams
GENESIS Pharma
GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative pharmaceutical products for severe and rare diseases in Central and Eastern Europe. Founded in 1997 in Greece, GENESIS Pharma S.A. was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. In 1999, business activities were expanded in Cyprus through the creation of GENESIS Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe. GENESIS Pharma (Cyprus) Ltd, an affiliate (sister) company, now operates in Central and Eastern Europe, through its subsidiaries in Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia (EU) as well as North Macedonia and Serbia (Non-EU). GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases. For more information, please visit www.genesispharmagroup.com and www.genesispharma.com